Rechallenge with imatinib in GIST: is more always RIGHT?

Urban,D, Lewin,J, Collins,IM, Mooi,J and Jefford,M 2014, Rechallenge with imatinib in GIST: is more always RIGHT?, Lancet Oncology, vol. 15, no. 1, pp. 2-3, doi: 10.1016/s1470-2045(13)70531-x.

Attached Files
Name Description MIMEType Size Downloads

Title Rechallenge with imatinib in GIST: is more always RIGHT?
Author(s) Urban,D
Collins,IMORCID iD for Collins,IM
Journal name Lancet Oncology
Volume number 15
Issue number 1
Start page 2
End page 3
Total pages 2
Publisher Lancet Publishing Group
Place of publication London, United Kingdom
Publication date 2014-01
ISSN 1470-2045
Language eng
DOI 10.1016/s1470-2045(13)70531-x
Field of Research 111299 Oncology and Carcinogenesis not elsewhere classified
Socio Economic Objective 920102 Cancer and Related Disorders
HERDC Research category C4.1 Letter or note
Copyright notice ©2014, Lancet Publishing Group
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 3 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 48 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Wed, 29 Apr 2015, 14:31:48 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact